6-methoxy-heptan-1-ol | 818-83-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 6-methoxy-heptan-1-ol
• 英文别名: 6-Methoxy-1-heptanol；6-methoxyheptan-1-ol
• CAS: 818-83-7
• 化学式: C₈H₁₈O₂
• 分子量: 146.23
• InChiKey: NFNLSVRTIYAZTO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-methoxy-heptan-1-ol 在 吡啶 、 氯化亚砜 作用下， 生成 (+/-)-7-Methoxy-octansaeure
  参考文献：
  名称：

  Michel,C.; Tchelitcheff,S., Bulletin de la Societe Chimique de France, 1964, p. 2230 - 2231

  摘要：

  DOI：
• 作为产物：
  描述：

  5-methoxy-hexan-1-ol 在 吡啶 、 氯化亚砜 作用下， 生成 6-methoxy-heptan-1-ol
  参考文献：
  名称：

  Michel,C.; Tchelitcheff,S., Bulletin de la Societe Chimique de France, 1964, p. 2230 - 2231

  摘要：

  DOI：

文献信息

• Echinocandin cyclic peptide derivatives
  申请人：Mizuno Hiroaki

  公开号：US20050181988A1

  公开（公告）日：2005-08-18

  This invention relates to new lipopeptide compound represented by the following general formula (I) wherein R 1 , R 2 , R 3 , R4 and R 5 are as defined in the description or a salt thereof which has antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or thereapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal. In particular, R 4 is an alkyl moiety which is substituted with an eventually protected and/or further substituted selected from amino, carboxy, guanidino, heterocyclic-carbonyl, alkyl-carbamoyl.

  本发明涉及一种新的脂肽化合物，其通式如下（I），其中R1、R2、R3、R4和R5如描述中所定义，或其盐具有抗微生物活性（特别是抗真菌活性），对β-1,3-葡聚糖合酶的抑制活性，制备方法，包括它的药物组合物，以及预防和/或治疗包括肺孢子虫感染（例如肺孢子虫肺炎）在人类或动物中的传染病的方法。特别地，R4是一种烷基基团，其被氨基、羧基、鸟氨酸、杂环羰基、烷基氨基酰等保护和/或进一步取代。
• [EN] NEW COMPOUND<br/>[FR] NOUVEAU COMPOSE
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2003068807A2

  公开（公告）日：2003-08-21

  This invention relates to new lipopeptide compound represented by the following general formula (I) wherein R1, R2, R3, R4 and R5 are as defined in the description or a salt thereof which has antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or thereapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal. In particular, R4 is an alkyl moiety which is substituted with an eventually protected and/or further substituted selected from amino, carboxy, guanidino, heterocyclic-carbonyl, alkyl-carbamoyl.